VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 18, Issue 2, 1998, Pages 49-61

  Hishida, Ryohei ^a,c   Nau, Heinz ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

Glutathione; Homocysteine; Methionine; Mice; Neural tube defects; Teratogenicity; Valproic acid

Indexed keywords

CYSTEINE; FOLIC ACID; GLUTATHIONE; HOMOCYSTEINE; METHIONINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; SERINE; SULFUR AMINO ACID; VALPROIC ACID;

AMINO ACID DEFICIENCY; AMINO ACID METABOLISM; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; TERATOGENESIS; VITAMIN INTAKE;

ABNORMALITIES, DRUG-INDUCED; AMINO ACIDS; ANIMALS; ANTICONVULSANTS; FEMALE; FOLIC ACID; GLUTATHIONE; HOMOCYSTEINE; LIVER; METHIONINE; MICE; NEURAL TUBE DEFECTS; PREGNANCY; VALPROIC ACID;

ANIMALIA;

EID: 0031668702     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(1998)18:2<49::AID-TCM1>3.0.CO;2-D     Document Type: Article

References (52)

1. Robert E, Guibaud P: Maternal valproic acid and congenital neural tube defects. Lancet 2:937, 1982.
2. Kao J, Brown NA, Schmid B, Goulding EH, Fabro S: Teratogenicity of valproic acid: In vivo and in vitro investigation. Teratogenesis Cartinog Mutagen 1:367-382, 1981.
3. Nau H: Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: Correlation with Neural tube defect formation in the mouse. Teratology 33:21-27, 1986.
4. Ehlers K, Stuerje H, Merker HJ, Nau H: Valproic acid-induced Spina bifida: A mouse model. Teratology 45:145-154, 1992.
5. Smithells RW, Sheppard S, Schorah CJ: Vitamin deficiencies and neural tube defects. Arch Dis Child 51:944-950, 1976.
6. Laurence KMNJ, Miller MH, Tennant GB, Campbell H: Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. Brit Med J 282:1509-1511, 1981.
7. Troz M, Wegner C, Nau H: Valproic acid-induced neural tube defects: Reduction by folinic acid in the mouse. Life Sci 41:103-110, 1987.
8. MRC Vitamin Study Research Group: Prevention of neural tube defects: Result of the medical research council vitamin study. Lancet 338: 131-137, 1991.
9. Czeizel AE, Dudus I: Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835, 1992.
10. 12 are independent risk factor for neural tube defects. Quarterly J Med 86:703-708, 1993.
11. 12-deficient rats. J Nutr 98:139-146, 1969.
12. Hansen DK: In vitro effects of folate derivatives on valproate-induced neural tube defects in mouse and rat embryos. Toxic in Vitro 7:735-742, 1993.
13. 12 alters the frequency of neural tube defects in Axd mutant mice. J Nutr 123:27-34, 1993.
14. Niiyama Y, Kishi K, Inoue G: Effect of diets devoid in one essential amino acid on pregnancy in rats maintained by ovarian steroids. J Nutr 100:1461-1470, 1970.
15. Coelho CND, Klein NW: Methionine and neural tube closure in cultured rat embryos: Morphological and biochemical analyses. Teratology 42:437-451, 1990.
16. Ehlers K, Elmazar MMA, Nau H: Methionine reduces the valproic acid-induced spina bifida rate in mice without altering valproic acid kinetics. J Nutr 126:67-75, 1996.
17. Steegers-Theunissen RPM, Boers GHJ, Trijbels JMF, Eskes TKAB: Neural-tube defects and derangement of homocysteine metabolism [letter]. N Engl J Med 324:199-200, 1991.
18. van per Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman ECM, den Heyer M, Rozen R, Blom HJ: Mutated methylene tetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071, 1995.
19. Held KD, Biaglow JE: Mechanism for the oxygen radical-mediated toxicity of various thiol-containing compounds in cultured mammalian cells. Radiat Res 139:15-23, 1994.
20. Jones BG, Rose FA, Tudball N: Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis 105:165-170, 1994.
21. Goto Y, Noda Y, Narimoto K, Umaoka Y, Mori T: Oxidative stress on mouse embryo development in vitro. Free Radical Biol Med 13:47-53, 1992.
22. Gardiner CS, Reed DJ: Status of glutathione during oxidant-induced oxidative stress in the preinaplantation mouse embryo. Biol Reprod 51:1307-1314, 1994.
23. VanAerts LAGJM, Klaasboer HH, Postma NS, Pertus JCLM, Copius Peereboom JHJ, Eskes TKAB, Noordhoek J: Sterospecific in vitro embryotoxicity of L-homocysteine in pre- and post-implantation rodent embryos. Toxic in Vitro 7:743-749, 1993.
24. Legge M, Sellens MH: Free radical scavengers ameliorate the 2-cell block in mouse embryo culture. Hum Reprod 6:867-871, 1991.
25. Di Ilio C, Tiboni GM, Sacchetta P, Angelucci S, Bucciarelli T, Bellati U, Aceto A: Time dependent and tissue specific variations of glutathione transferase activity during gestation in the mouse. Mech Ageing Dev 78:47-62, 1995.
26. Brown NA, Farmer PB, Coakley M: Valproic acid teratogenicity: Demonstration that the biochemical mechanism differs from that of valproate hepatotoxicity. Biochem Soc Trans 13:75-77, 1985.
27. VanAerts LAGJM, Poirot CM, Herberts CA, Blom HJ, De Abreu RA, Trijbels JM, Eskes TK, Peereboom Stegeman JH, Noordhoek J: Development of methionine synthase, cystathionine-β-synthase and S-adenosyl-homocysteine hydrolase during gestation in rats. J Reprod Fertil 103:227-232, 1995.
28. Cornwell PE, Morgan SL, Vaughn WH: Modification of a high-performance liquid Chromatographic method for assay of homocysteine in human plasma. J Chromatogr 617:136-139, 1993.
29. Ubbink JB, Hayward Vermaak WJ, Bissbort S: Rapid high-performance liquid Chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565:441-446, 1991.
30. Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422:43-52, 1987.
31. Jones BN, Gilligan JP: o-phthaldialdehyde precolumn derivatization and reverse-phase high-performance liquid chromatography of polypeptide hydrolysates and physiological fluids. J Chromatogr 266:471-482, 1983.
32. Fell D, Benjamin LE, Steele RD: Determination of adenosine and S-adenosyl derivatives of sulfur amino acids in rat liver by high-performance liquid chromatography. J Chromatogr 345:150-156, 1985.
33. Sullivan DM, Hoffman JL: Fractionation and kinetic properties of rat liver and kidney methionine adenosyltransferase isozymes. Biochemistry 22:1636-1641, 1983.
34. Finkelstein JD: Methionine metabolism in mammals. J Nutr Biochem 1:228-237, 1990.
35. Cantoni GL: Activation of methionine for transmethylation. J Biol Chem 189:745-754, 1951.
36. Finkelstein JD, Mudd SH: Trans-sulfuration in mammals. J Biol Chem 242:873-880, 1967.
37. Finkelstein JD, Kyle WE, Martin JJ, Pick AM: Activation of cystathionine synthase by adenosylmethionine and adenosylethionine. Biochem Biophys Res Commun 66:81-87, 1975.
38. Wegner C. Nau H: Alternation of embryonic folate metabolism by valproic acid during organogenesis: Implications for mechanism of teratogenesis. Neurology 42:17-24, 1992.
39. Kutzbach C, Stokstad ELR: Mammalian methylenetetrahydrofolate reductase; partial purification, properties, and inhibition by S-adenosylmethionine. Biochim Biophys Acta 250:459-477, 1971.
40. Lee HY, Nagal RG: Studies on the mechanisms of neurulation in the chick: Interrelationship of contractile proteins, microfilaments, and the shape of neuroepithelial cells. J Exp Zool 235:205-215, 1985.
41. Moephuli SR, Klein NW, Baldwin MT, Krider HM: Effects of methionine on the cytoplasmic distribution of actin and tubulin during neural tube closure in rat embryos. Proc Natl Acad Sci USA 94:543-548, 1997.
42. Andersson A, Hultgerg B, Brattstroem L, Isaksson A: Decreased serum homocysteine in pregnancy. Nur J Clin Chem Clin Biochem 30:377-379, 1992.
43. Saez G, Thornalley PJ, Hill HAO, Hems R, Bannister JV: The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes. Biochim Biophys Acta 719:24-31, 1982.
44. Neubert D, Lehninger AL: The effect of thiols and disulfides on water uptake and extrusion by rat liver mitochondria. J Biol Chem 237:952-958, 1962.
45. Olney JW, Ho OL, Rhee V, Schainker B: Cysteine induced brain damage in infant and fetal rodents. Brain Res 45:309-313, 1972.
46. Kumar S, Foreman JR: Amniotic fluid and maternal serum amino acid levels in malformations of fetal central nervous system. Neurochem Res 5:453-458, 1980.
47. Cotariu D, Evans S, Zaidman JL, Marcus O: Early changes in hepatic redox homeostasis following treatment with a single dose of valproic acid. Biochem Pharmacol 40:589-593, 1990.
48. Cotariu D, Evans S, Lahat E, Theitler J, Bistritzer T, Zaidman JL: Inhibition of human red blood cell glutathione reductase by valproic acid. Biochem Pharmacol 43:425-429, 1992.
49. Jezequel AM, Bonazzi P, Novelli G, Venturini C, Orlandi F: Early structural and functional changes in liver of rats treated with a single dose of valproic acid. Hepatology 4:1159-1166, 1984.
50. Graf WD, Pippenger CE, Shurtleff DB: Erythrocyte antioxidant enzyme activities in children with myelomeningocele. Dev Med Child Neurol 37:900-905, 1995.
51. Tang W, Borel AG, Abbott FS: Conjugation of glutathione with a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, catalyzed by rat hepatic glutathione-S-transferases. Drug Metab Dispos 24:436-446, 1996.
52. Rogiers V, Callaerts A, Vercruysse A, Akrawi M, Shephard E, Phillips I: Effects of valproate on xenobiotic biotransformation in rat liver. In vivo and in vitro experiments. Pharm Weekbl Sci 14:127-131, 1992.